We collect cookies for vital website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.


Item № 17593
CAS № 36099-95-3
Purity ≥98%
product image
                (CAS 36099-95-3)
     10 mg $25.00 0.00
     25 mg $53.00 0.00
     50 mg $79.00 0.00
     100 mg $150.00 0.00

Pricing updated 2019-07-23. Prices are subject to change without notice.


Peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear receptor with key roles in adipocyte differentiation and glucose homeostasis.1,2 G3335 is a cell-permeable dipeptide that potently antagonizes PPARγ (Kd = 8.34 µM).3 It reversibly and competitively blocks activation of PPARγ by rosiglitazone (IC50 = 8-32 µM).3 G3335 is active in vivo, abolishing the protective effects of rosiglitazone in experimental spinal cord injury in rats.4 G3335 has also been used to evaluate the role of PPARγ in neurotoxicity studies.5,6

Recommended Products

Related Products
View Related Product Categories
Technical Information
Formal Name
L-tryptophyl-L-glutamic acid
CAS Number
Molecular Formula
Formula Weight
A crystalline solid
218, 278, 288 nm
InChI Code
InChI Key

Warning - this product is not for human or veterinary use.

Shipping & Storage
Room temperature in continental US; may vary elsewhere
≥ 2 years
Downloads & Resources
Product Downloads

Download Product Insert

Download Safety Data Sheet (SDS)

Download free InChI Key generation software

Additional Information

View the Cayman Structure Database for chemical structure definitions for many Cayman products

Get Batch-Specific Data and Documents by Batch Number

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.

References & Product Citations
Product Description References

1. Heikkinen, S., Auwerx, J., and Argmann, C.A. PPARγ in human and mouse physiology Biochimica et Biophysica Acta 1771(8), 999-1013 (2007).

2. Michalik, L., Auwerx, J., Berger, J.P., et al. International union of pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacological Reviews 58, 726-741 (2006).

3. Ye, F., Zhang, Z.S., Luo, H.B., et al. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARγ: Bioassay with molecular modeling simulation ChemBioChem 7, 74-82 (2006).

4. Meng, Q.Q., Liang, X.J., Wang, P., et al. Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury Neuroscience Letters 503, 191-195 (2011).

5. Di Cesare Mannelli, L., Zanardelli, M., Micheli, L., et al. PPAR-γ impairment alters peroxisome functionality in primary astrocyte cell cultures Biomed.Res.Int. 2014, 1-12 (2014).

6. Zanardelli, M., Micheli, L., Cinci, L., et al. Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach PLoS One 9(7), 1-15 (2014).

Technical Support
Contact Us
  • Toll Free Phone (USA and Canada Only): (888) 526-5351
  • Direct Phone: (734) 975-3888
Cayman Contract Services

We work with scientists to accelerate their research, drug discovery, and drug development needs through our expertise in the following areas:

Cayman Chemical

1180 East Ellsworth Road

Ann Arbor, Michigan 48108 USA

Toll Free: (800) 364-9897

(USA and Canada Only)

Fax: (734) 971-3640